Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | XRD-0394 |
| Synonyms | |
| Therapy Description |
XRD-0394 inhibits ATM and DNA-PK, potentially resulting in impaired DNA damage repair and inhibition of tumor growth (PMID: 38588408). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| XRD-0394 | XRD 0394|XRD0394 | ATM Inhibitor 13 DNA_PK Inhibitor 9 | XRD-0394 inhibits ATM and DNA-PK, potentially resulting in impaired DNA damage repair and inhibition of tumor growth (PMID: 38588408). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06829173 | Phase I | XRD-0394 | Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas | Not yet recruiting | USA | 0 |
| NCT05002140 | Phase I | XRD-0394 | Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | Completed | USA | 0 |